Menu
Subscribe to our Email Alerts
About Us
Island at a glance
Board
Key Management
Scientific Advisory Board
Collaborations
Science
About ISLA-101
Scientific Publications
Drug repurposing and benefits
Disease and drug terms explained
Investor Centre
Investor Welcome
Clinical programme
ASX Announcements
Presentations
Prospectus
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
Media
News
IslandWatch Newsletter
Contact
Contact Us
Subscribe for Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Investor Welcome
Clinical programme
ASX Announcements
Presentations
Prospectus
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
ASX Announcements
Filter by Year:
2024
2023
2022
2021
17-Apr-2023
Island submits responses to FDA questions for ISLA-101
13-Apr-2023
Application for quotation of securities - ILA
4-Apr-2023
Appendix 3Y - Albert Hansen
4-Apr-2023
Notification of cessation of securities - ILA
3-Apr-2023
Release of Securities from Escrow
23-Feb-2023
Appendix 4D & Half-Year Financial Statements
7-Feb-2023
Change in substantial holding
1-Feb-2023
ILA receives additional FDA feedback on IND for ISLA 101
30-Jan-2023
Quarterly Activity Report & Appendix 4C
20-Jan-2023
Island receives FDA feedback on Phase 2a clinical study
Previous
1
2
3
4
.png){kind=logo}
